Most brain hemangiomas are not immediately dangerous, but they do carry a small ongoing risk of bleeding that makes them worth monitoring. The term “brain hemangioma” usually refers to a cerebral cavernous malformation (also called a cavernoma), a cluster of tightly packed, abnormal blood vessels with thin walls. These lesions are typically smaller than half an inch, contain slow-moving or clotted blood, and many people live with them for years without ever knowing they’re there.
The real question isn’t a simple yes or no. It depends on where in the brain the lesion sits, whether it has bled before, and whether you have one or several.
What a Brain Hemangioma Actually Is
A cavernous malformation looks like a small mulberry: a tangle of irregular, thin-walled blood vessels packed closely together. Unlike the high-pressure blood flow in an arteriovenous malformation (AVM), the blood inside a cavernoma moves slowly and often clots. These lesions can form anywhere in the brain or spinal cord, though they’re most commonly found in the brain itself.
Most cavernomas are sporadic, meaning they appear as a single lesion with no family connection. About 20% of cases run in families, caused by inherited changes in one of three genes (known as CCM1, CCM2, or CCM3). People with the familial form typically develop multiple lesions rather than just one, which changes the overall risk picture. If you have a close relative with a cavernoma, genetic testing can clarify whether you carry one of these gene variants.
The Risk of Bleeding
The annual risk of a cavernoma bleeding for the first time is relatively low: between 0.6% and 1.1% per year. To put that in perspective, if 100 people each had a cavernoma, roughly one of them would experience a bleed in any given year. Many people go their entire lives without a hemorrhage.
The picture changes significantly after a first bleed. Prior hemorrhage is the single biggest risk factor for another one, pushing the rehemorrhage risk to roughly 20% within the first two years. Each additional bleed further increases the odds of the next, creating a pattern where repeated hemorrhages become the central concern rather than the initial one.
Why Location Matters So Much
A cavernoma in a relatively “quiet” part of the brain may bleed and cause only a mild headache or no symptoms at all. The same size bleed in the brainstem, which controls breathing, swallowing, and consciousness, can be life-threatening.
The numbers reflect this difference clearly. The annual rehemorrhage rate for brainstem cavernomas is about 11%, compared to 6.8% for those located elsewhere. After a first hemorrhage, overall morbidity (meaning lasting disability of some kind) reaches 31.3% for brainstem lesions versus 21% for non-brainstem locations. Moderate or severe disability occurs in nearly 19% of brainstem cases. A brainstem location roughly triples the odds of lasting harm compared to other sites in the brain.
Symptoms to Recognize
Many cavernomas produce no symptoms at all and are discovered incidentally during an MRI for something else entirely. When symptoms do appear, they typically fall into a few categories:
- Seizures: the most common symptom, especially for lesions near the brain’s surface. Blood products leaking from the malformation irritate surrounding brain tissue.
- Headaches: can range from mild to severe, sometimes mimicking migraines.
- Neurological deficits: weakness, numbness, vision changes, difficulty speaking, or problems with coordination, depending on where the lesion is located.
- Brainstem-specific symptoms: double vision, trouble swallowing, facial numbness, or balance problems if the lesion sits in the brainstem.
A sudden worsening of any of these symptoms often signals a new bleed. Symptoms from small hemorrhages sometimes resolve over weeks to months as the blood is reabsorbed, but repeated bleeds can cause cumulative damage.
How It’s Diagnosed
MRI is the gold standard for identifying cavernomas. On imaging, these lesions have a distinctive “popcorn” appearance: a core of mixed signals created by pockets of blood at different stages of aging, surrounded by a dark rim of iron deposits left behind by old bleeds. Specialized MRI sequences that are highly sensitive to blood products can pick up even tiny lesions that standard scans might miss. The lesions typically show little or no enhancement with contrast dye and minimal surrounding swelling, which helps distinguish them from tumors.
When Surgery Is Recommended
Not every cavernoma needs surgery. For a lesion that has never bled and causes no symptoms, observation with periodic MRI is the standard approach. There are no firmly established intervals for routine follow-up imaging, but repeat MRI is recommended whenever new or worsening symptoms appear.
Surgery becomes a stronger consideration in specific scenarios. A life-threatening hemorrhage (causing coma or breathing problems) or a severe bleed with major functional impairment like paralysis or difficulty swallowing generally favors surgical removal. Repeated bleeds that cluster together over days or weeks also push toward intervention, because that pattern signals a high risk of further hemorrhage. Conversely, a single mild bleed with minor sensory symptoms typically argues against rushing to the operating room, since recovery from the bleed itself can often be expected.
Location plays a critical role in surgical decision-making. Lesions that reach the brain’s surface or the lining of the ventricles (fluid-filled spaces inside the brain) are generally more accessible and carry lower surgical risk. Deep-seated lesions near critical pathways that control movement or eye coordination pose a much higher operative risk, and surgeons weigh that carefully against the risk of doing nothing. For brainstem cavernomas larger than 2 to 3 centimeters, the surgery itself becomes technically more difficult because the lesion can distort normal anatomy.
Focused Radiation as an Alternative
For cavernomas in locations that are too risky for open surgery, stereotactic radiosurgery (a precisely targeted form of radiation) is sometimes used. A large multi-center study found that this approach reduced the annual hemorrhage rate from about 11% to 2.7% after treatment. The cumulative risk of a first bleed after radiosurgery was 9.4% at five years and 15.6% at ten years.
The trade-off is radiation-related side effects. About 11% of treated lesions developed adverse radiation effects on imaging, though only 3.9% of patients experienced temporary neurological symptoms from the radiation, and just 1.1% had permanent deficits. Larger lesions and higher radiation doses were linked to greater complication risk.
Pregnancy and Hormonal Concerns
If you’ve been diagnosed with a cavernoma and are considering pregnancy, the data is reassuring. A prospective study tracking women with known brain or spinal cord cavernomas found zero hemorrhages during 32 pregnancies, covering nearly 27 years of pregnancy time. This compared to a 10.4% annual hemorrhage rate in the same women while not pregnant. The difference was not statistically significant, meaning pregnancy does not appear to raise bleeding risk. Vaginal delivery was also considered safe in appropriate candidates. Researchers have looked for estrogen and progesterone receptors on cavernoma tissue and largely come up empty, which helps explain why hormonal shifts during pregnancy don’t seem to destabilize these lesions.
Living With a Cavernoma
For the majority of people, a brain cavernoma is a condition to monitor rather than an emergency to treat. The key factors that determine your personal risk level are whether the lesion has bled before, where it’s located, and whether you have single or multiple lesions. A single, never-bled cavernoma in a non-critical area of the brain carries a very low annual risk and may never cause problems. A brainstem lesion with a history of repeated hemorrhages is a fundamentally different situation that often requires active intervention.
Periodic MRI monitoring, awareness of new symptoms, and an ongoing relationship with a neurologist or neurosurgeon who specializes in vascular malformations give you the best framework for managing the condition over time. If your cavernoma was found incidentally and has never caused symptoms, the odds are strongly in your favor that it will stay quiet.